FULCRUM THERAPEUTICS, INC.

Profile

Company Names

FULCRUM THERAPEUTICS, INC.

Addresses

26 LANDSDOWNE STREET, CAMBRIDGE, MA 02139

ONE KENDALL SQUARE, BUILDING 700, SUITE B7102, CAMBRIDGE, MA 02139

Phone Numbers

617-651-8851

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2015

State Incorporated:

DELAWARE

Total Amount Raised:

$183,166,653.00

Number of Funding Rounds:

4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2020-06-09 
$68,499,987.00 
$68,499,987.00 
$0.00 
Equity 
3
2018-08-24 
$80,000,000.00 
$80,000,000.00 
$0.00 
Equity 
2
2017-04-28 
$5,000,000.00 
$5,000,000.00 
$0.00 
Equity 
1
2016-07-18 
$29,666,666.00 
$55,000,000.00 
$25,333,334.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
DIEGO 
 
CADAVID 
EXECUTIVE OFFICER
FULCRUM THERAPEUTICS, INC.   |  X4 PHARMACEUTICALS, INC
JAMES 
 
COLLINS 
DIRECTOR
SAF-T-PAY, INC   |  MOTHER AFRICKA PARTNERS LLC   |  PHOTO HOLDINGS, INC.   |  BCB BANCORP INC   |  FULCRUM THERAPEUTICS, INC.   |  SHERLOCK BIOSCIENCES, INC.   |  AWAKN LIFE SCIENCES INC.   |  BAREFOOT BITCOIN FUND I LLC   |  GOLOCKER ENTERPRISES, INC.   |  AWAKN LIFE SCIENCES CORP.   |  BEFORE SELF CARE CO INC.   |  SENTI BIOSCIENCES, INC.
KATINA 
 
DORTON 
DIRECTOR
AVROBIO, INC.   |  FULCRUM THERAPEUTICS, INC.
ALAN 
 
EZEKOWITZ 
DIRECTOR
ABIDE THERAPEUTICS, INC.   |  FULCRUM THERAPEUTICS, INC.   |  SEPTERNA, INC.   |  CORNER THERAPEUTICS, INC.
JAMES 
 
GERAGHTY 
DIRECTOR
VOYAGER THERAPEUTICS, INC.   |  IMMUNEXCITE, INC.   |  FULCRUM THERAPEUTICS, INC.   |  PIERIS PHARMACEUTICALS, INC.
ROBERT 
 
GOULD 
EXECUTIVE OFFICER, DIRECTOR
FULCRUM THERAPEUTICS, INC.   |  HEMOSHEAR THERAPEUTICS, LLC   |  TURNSTONE BIOLOGICS CORP.   |  FAETH THERAPEUTICS, INC.   |  SPINNAKER LINCOLN PARK LLC
AMIT 
 
HASIJA 
EXECUTIVE OFFICER
FULCRUM THERAPEUTICS, INC.
KATE 
 
HAVILAND 
DIRECTOR
FULCRUM THERAPEUTICS, INC.
MARK 
 
LEVIN 
DIRECTOR
NINEPOINT MEDICAL, INC.   |  ELEVEN BIOTHERAPEUTICS, INC.   |  CONSTELLATION PHARMACEUTICALS INC   |  FOUNDATION MEDICINE, INC.   |  KARSAMERICA FINANCE LLC   |  DC DEVICES, INC.   |  THIRD ROCK VENTURES III, L.P.   |  ALLSTAR DEALS, INC.   |  MAKI SHOP STORE 1 LLC   |  ROLL-D HOLDINGS, LLC   |  VOYAGER THERAPEUTICS, INC.   |  CORVIA MEDICAL, INC.   |  FULCRUM THERAPEUTICS, INC.   |  MAKI SHOP STORE 3 LLC   |  HIRSHMARK CAPITAL REIT LLC
BRYAN 
 
STUART 
EXECUTIVE OFFICER
CIVITAS THERAPEUTICS, INC.   |  FULCRUM THERAPEUTICS, INC.
JAMES 
 
TANANBAUM 
DIRECTOR
VITAE PHARMACEUTICALS, INC   |  TARSA THERAPEUTICS, INC.   |  WAVETEC VISION SYSTEMS INC   |  ALLERGEN RESEARCH CORP   |  FULCRUM THERAPEUTICS, INC.   |  INTERLINE THERAPEUTICS, INC.   |  FL2021-001, INC.   |  EIKON THERAPEUTICS, INC.   |  FL2020-004, INC.   |  FORESITE CAPITAL FUND VI LP   |  FORESITE CAPITAL FUND VI (FEEDER), LP   |  ALUMIS INC.
OWEN 
 
WALLACE 
EXECUTIVE OFFICER
FULCRUM THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2020-06-11
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2020-06-09 
2018-09-05
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-08-24 
2017-07-25
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-07-18 
2017-05-10
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-04-28 
2016-07-25
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-07-18 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
SVB LEERINK LLC
39011